Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-cell Acute Lymphoblastic Leukemia.

Bayet M, Fregona V, Bouttier M, Rouzier C, Bigot J, Jamrog L, Hebrard S, Prade N, Lagarde S, Didier C, Gachet S, Passet M, Largeaud L, Pasquet M, Khamlichi AA, Clappier E, Delabesse E, Broccardo C, Gerby B

Open source

DOI: 10.1158/0008-5472.can-24-1698
Published: 2025 Aug 1
Container: Cancer research
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/0008-5472.can-24-1698,
  title = {Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-cell Acute Lymphoblastic Leukemia.},
  author = {Bayet M and Fregona V and Bouttier M and Rouzier C and Bigot J and Jamrog L and Hebrard S and Prade N and Lagarde S and Didier C and Gachet S and Passet M and Largeaud L and Pasquet M and Khamlichi AA and Clappier E and Delabesse E and Broccardo C and Gerby B},
  year = {2025},
  journal = {Cancer research},
  doi = {10.1158/0008-5472.can-24-1698},
  url = {https://doi.org/10.1158/0008-5472.can-24-1698}
}

RIS

TY  - JOUR
TI  - Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-cell Acute Lymphoblastic Leukemia.
AU  - Bayet M
AU  - Fregona V
AU  - Bouttier M
AU  - Rouzier C
AU  - Bigot J
AU  - Jamrog L
AU  - Hebrard S
AU  - Prade N
AU  - Lagarde S
AU  - Didier C
AU  - Gachet S
AU  - Passet M
AU  - Largeaud L
AU  - Pasquet M
AU  - Khamlichi AA
AU  - Clappier E
AU  - Delabesse E
AU  - Broccardo C
AU  - Gerby B
PY  - 2025
JO  - Cancer research
DO  - 10.1158/0008-5472.can-24-1698
UR  - https://doi.org/10.1158/0008-5472.can-24-1698
ER  -

APA

M, B., V, F., M, B., C, R., J, B., L, J., S, H., N, P., S, L., C, D., S, G., M, P., L, L., M, P., AA, K., E, C., E, D., C, B., & B, G. (2025). Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-cell Acute Lymphoblastic Leukemia.. Cancer research. https://doi.org/10.1158/0008-5472.can-24-1698

Source records

pubmed · retrieved 2026-09-26T10:40:52.072Z